Results 71 to 80 of about 5,791,370 (216)

Invasive meningococcal disease in Navarra in the era of a meningococcal C vaccine

open access: yesAnales de Pediatría (English Edition), 2017
Systematic childhood vaccination against meningococcus C has had a considerable impact on meningococcal invasive disease (MID). The aim of this study is to perform an analysis on the epidemiology, the clinical features, and the factors associated with a worse prognosis of MID, in the era of a meningococcal C vaccine.The study included confirmed cases ...
Desirée, Morales   +5 more
openaire   +2 more sources

Meningococcemia in a vaccinated child receiving eculizumab and review of the literature

open access: yesThe Turkish Journal of Pediatrics, 2023
Background. Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by uncontrolled activation and dysregulation of the alternative complement pathway and development of thrombotic microangiopathy. Eculizumab, which is
Diana Üçkardeş   +5 more
doaj   +1 more source

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money   +5 more
wiley   +1 more source

Evaluation of the Completeness of Reporting of Invasive Meningococcal Disease [PDF]

open access: yesCanadian Journal of Public Health, 1999
VOLUME 90, NO. 4 In Quebec, the annual number of reported cases of invasive meningococcal disease (IMD) increased from 37 in 1984 to 124 in 1990. The increase and the emergence of a virulent strain of serogroup C prompted the Ministere de la Sante et des Services sociaux (Provincial Ministry of Health) to immunize all children aged 6 months to 19 years
P, Rivest, B, Sagot, L, Bédard
openaire   +2 more sources

Management of Refractory Thymoma‐Associated Myasthenia Gravis With Sequential FcRn Antagonist and Complement Inhibition Combined With Resection of Pleural Dissemination

open access: yesNeurology and Clinical Neuroscience, EarlyView.
ABSTRACT Myasthenia gravis (MG) associated with disseminated thymoma is often refractory to conventional treatments due to continuous autoantibody production. The optimal treatment strategy, particularly the combination of complement component 5 (C5) inhibitor, neonatal Fc receptor (FcRn) antagonist, and surgical resection in thymoma‐associated ...
Hiroyuki Takenaka   +3 more
wiley   +1 more source

A Decade of Invasive Meningococcal Disease Surveillance in Poland

open access: yesPLoS ONE, 2013
Neisseria meningitidis is a leading etiologic agent of severe invasive disease. The objective of the study was to characterise invasive meningococcal disease (IMD) epidemiology in Poland during the last decade, based on laboratory confirmed cases.The study encompassed all invasive meningococci collected between 2002 and 2011 in the National Reference ...
Skoczyńska, Anna   +14 more
openaire   +4 more sources

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity. [PDF]

open access: yes, 2012
Despite the success of conjugate vaccination against meningococcal group C (MenC) disease, post-vaccination, some individuals still exhibit rapid waning of initially protective bactericidal antibody levels.
Findlow, J.   +44 more
core   +2 more sources

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

open access: yesInternal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard   +13 more
wiley   +1 more source

Risk and protective factors for meningococcal disease in adolescents: matched cohort study [PDF]

open access: yes, 2006
Objective: To examine biological and social risk factors for meningococcal disease in adolescents. Design: Prospective, population based, matched cohort study with controls matched for age and sex in 1:1 matching.
Stuart, J.M.   +9 more
core  

Sampling methods to detect carriage of Neisseria meningitidis; literature review.

open access: yes, 2009
OBJECTIVES: Studies of meningococcal carriage are important in understanding the epidemiology of meningococcal disease and the impact of vaccination programmes. However, microbiological sampling methods to determine pharyngeal carriage are not consistent
Stuart, James   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy